Karthik Radhakrishnan Monopar Therapeutics (MNPR) insider trading activity
Karthik Radhakrishnan is Chief Financial Officer of Monopar Therapeutics. Currently has a direct ownership of 1,550 shares of MNPR, which is worth approximately $22,676. The most recent transaction as insider was on Oct 28, 2024, when has been sold 1,550 shares (Common Stock) at a price of $16.25 per share, resulting in proceeds of $25,187. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.55K
n/a
3M change
n/a
12M change
Total Value Held
$22,676
KR
Karthik Radhakrishnan
Chief Financial Officer
Wilmette, IL